| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 200.83B | 188.53B | 221.25B | 192.77B | 117.01B |
| Gross Profit | 89.78B | 103.92B | 110.00B | 88.84B | 58.44B |
| EBITDA | 29.26B | 41.24B | 48.91B | 33.79B | 17.28B |
| Net Income | 8.73B | 19.60B | 26.13B | 19.76B | 7.48B |
Balance Sheet | |||||
| Total Assets | 167.62B | 170.31B | 186.84B | 193.94B | 118.43B |
| Cash, Cash Equivalents and Short-Term Investments | 44.54B | 72.84B | 69.74B | 45.14B | 46.27B |
| Total Debt | 0.00 | 1.63B | 2.04B | 1.13B | 0.00 |
| Total Liabilities | 34.57B | 33.27B | 55.82B | 84.08B | 28.82B |
| Stockholders Equity | 133.06B | 137.05B | 131.02B | 109.86B | 89.61B |
Cash Flow | |||||
| Free Cash Flow | -7.16B | 19.11B | 41.00B | 5.39B | 8.81B |
| Operating Cash Flow | 7.69B | 31.87B | 52.88B | 18.02B | 16.36B |
| Investing Cash Flow | -22.88B | -14.55B | -23.16B | -19.73B | -7.94B |
| Financing Cash Flow | -14.24B | -13.82B | -6.62B | -333.00M | -458.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥398.91B | 20.75 | ― | 2.29% | 6.52% | -54.63% | |
76 Outperform | ¥2.01T | 7.87 | 12.05% | 1.50% | 9.27% | 3.50% | |
75 Outperform | ¥12.07T | 22.92 | 9.29% | 1.19% | 6.76% | 27.25% | |
69 Neutral | ¥7.54T | 43.08 | 32.32% | 0.91% | 20.73% | 72.44% | |
68 Neutral | ¥3.58T | 27.94 | 10.06% | 1.21% | 8.80% | 117.61% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥1.59T | 36.88 | 8.39% | 1.49% | 0.83% | -37.84% |